Your request has been received.
We will send you more information as it becomes available.
days to go: ASP+6% CMS reimbursement for proven non-opioids used in all outpatient surgical settings is coming January 1, 2025.
For adults, a maximum dose of 266 mg (20 mL) is recommended, based on:
For pediatric patients aged 6 to less than 17 years, dosing is weight based: 4 mg/kg (up to a maximum of 266 mg)
For interscalene brachial plexus nerve block in adults, the recommended dose is 133 mg (10 mL), based on a study of patients undergoing rotator cuff repair or total shoulder arthroplasty
For adductor canal block in adults, the recommended dose is 133 mg (10 mL) admixed with 50 mg (10 mL) 0.5% bupivacaine HCl, for a total volume of 20 mL, based on a study of patients undergoing total knee arthroplasty
For sciatic nerve block in the popliteal fossa in adults, the recommended dose is 133 mg (10 mL), based on a study of patients undergoing bunionectomy
See how your peers are using EXPAREL for optimal pain coverage
Multimodal approaches with or without ERAS protocols have demonstrated benefits in hip surgery
Retrospective study comparing the efficacy of standard THA pain management with adjunct EXPAREL (n=586) versus standard THA pain management alone (n=686) in patients undergoing THA.
*The use of EXPAREL in combination with epinephrine is not part of the approved label.
†Opioid intake measured in MED (mg).
‡The clinical benefit of the decrease in opioid consumption was not demonstrated in the pivotal trials.
MED, morphine equivalent dosing; THA, total hip arthroplasty;
Retrospective chart review that analyzed the outcome and feasibility of same-day discharge using an ERAS protocol in the inpatient setting in Medicare patients undergoing TKA (n=337) or THA (n=308).
*The clinical benefit of the decrease in opioid consumption was not demonstrated in the pivotal trials.
ERAS, enhanced recovery after surgery; THA, total hip arthroplasty; TKA, total knee arthroplasty.
ASP, average sales price; CMS, Centers for Medicare and Medicaid Services.
EXPAREL® (bupivacaine liposome injectable suspension) is indicated to produce postsurgical local analgesia via infiltration in patients aged 6 years and older and regional analgesia in adults via an interscalene brachial plexus nerve block, sciatic nerve block in the popliteal fossa, and an adductor canal block. Safety and efficacy have not been established in other nerve blocks.
Please refer to full Prescribing Information.
EXPAREL® (bupivacaine liposome injectable suspension) is indicated to produce postsurgical local analgesia via infiltration
This website uses cookies to give you a better browsing experience. By clicking the "Allow all cookies" button, you agree to our use of cookies. For additional information, see our Cookie Notice.